Skip to content
10-K

Annual Report

CYCLERION THERAPEUTICS, INC. CYCN

0001193125-26-132193

← back to feed
Filed
Mar 30, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 26, 2026 4.33M sh
Shares Diluted FY 2025 · Dec 31, 2025 3.18M sh
Operating Cash Flow FY 2025 · Dec 31, 2025 −$3.31M
Cash And Equivalents FY 2025 · Dec 31, 2025 $3.24M
Stockholders Equity FY 2025 · Dec 31, 2025 $9.09M
Current Liabilities FY 2025 · Dec 31, 2025 $900K
Current Assets FY 2025 · Dec 31, 2025 $4.64M
Total Assets FY 2025 · Dec 31, 2025 $9.99M
Eps Diluted FY 2025 · Dec 31, 2025 −$1.11
Eps Basic FY 2025 · Dec 31, 2025 −$1.11
Sga Expense FY 2025 · Dec 31, 2025 $6.09M
Rd Expense FY 2025 · Dec 31, 2025 $959K
Net Income FY 2025 · Dec 31, 2025 −$3.53M
Operating Income FY 2025 · Dec 31, 2025 −$4.97M